Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion
Open Access
- 25 May 2023
- journal article
- review article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 110, 42-57
Abstract
No abstract availableKeywords
Funding Information
- Eisai Incorporated
- Catholic Medical Center (GPP 2022)
This publication has 125 references indexed in Scilit:
- Determining the Relative Efficacy of Positive Allosteric Modulators of the GABAA Receptor: Design of a Screening ApproachSLAS Discovery, 2014
- De novo mutations in epileptic encephalopathiesNature, 2013
- Effectiveness and tolerability of rufinamide in children and young adults with Lennox–Gastaut syndrome: A single center study in KoreaClinical Neurology and Neurosurgery, 2013
- GABAA Receptor Physiology and Its Relationship to the Mechanism of Action of the 1,5-Benzodiazepine ClobazamCNS Drugs, 2012
- Randomized, phase III study results of clobazam in Lennox-Gastaut syndromeNeurology, 2011
- Experience With Rufinamide in a Pediatric Population: A Single Center's ExperiencePediatric Neurology, 2010
- Mechanism of action of benzodiazepines on GABA A receptorsBritish Journal of Pharmacology, 2006
- Felbamate in Epilepsy TherapyDrug Safety, 1999
- Carbamazepine-exacerbated epilepsy in children and adolescentsPediatric Neurology, 1986
- Treatment of Generalized Epilepsies of Childhood and Adolescence with Sodium Valproate (‘Epilim’)Developmental Medicine & Child Neurology, 1977